KARD

Conviction 0HealthcareScan · Thu, Jun 25, 2026

KARD$22.03-0.94%

ResistanceSupportVol 14Insider buy

Jun 18Jun 22Jun 23Jun 24

Kardigan, Inc.Pharmaceutical Preparations

Price22.03

Change-0.94%

Gap-2.52%

Rel volume0.19×

Avg volume1.95M

Avg $ vol43.05M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrend—

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high22.77

52w low22.00

From 52w high-3.25%

Above 52w low+0.14%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)—

vs AVWAP high—

AVWAP (52w low)—

vs AVWAP low—

OBV trend—

Chaikin MF (20)—

Today vs 20d0.19×

Avg vol (14d)—

Avg vol (20d)1.95M

Avg $ vol (20d)43.05M

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank61.8

1 week—

1 month—

3 months—

6 months—

1 year—

YTD+0.14%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float38.13M

Float %42.7%

Short interest—

Days to cover—

Short volume85.4%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank61.8 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in KARD

All disclosures →

No recent disclosed trades by Congress in KARD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KARD · 5 buys · 5 sells

Insider	Side	Shares	Value	Traded	Filed
BERNS PAUL L Director · Common Stock · 2026-06-22	Buy	1.25M	$20M	2026-06-22	2026-06-24
ARCH Venture Partners XIII, LLC Director · Common Stock · 2026-06-22	Buy	1.25M	$20M	2026-06-22	2026-06-24
GIANAKAKOS ANASTASIOS President & CEO · Series A Preferred Stock · 2026-06-17	Convert	25.74K	—	2026-06-17	2026-06-22
GIANAKAKOS ANASTASIOS President & CEO · Series B Preferred Stock · 2026-06-17	Convert	313.09K	—	2026-06-17	2026-06-22
HRTG GPE, LLC 10% owner · Series A Redeemable Convertible Preferred Stock · 2026-06-17	Convert	3.86M	—	2026-06-17	2026-06-22
BERNS PAUL L Director · Common Stock · 2026-06-17	Convert	13.79M	—	2026-06-17	2026-06-22
GIANAKAKOS ANASTASIOS President & CEO · Series A Preferred Stock · 2026-06-17	Convert	18.02K	—	2026-06-17	2026-06-22
Walbert Timothy P Director · Common Stock · 2026-06-17	Grant	20.71K	—	2026-06-17	2026-06-22
GIANAKAKOS ANASTASIOS President & CEO · Common Stock · 2026-06-17	Convert	28.7K	—	2026-06-17	2026-06-22
ARCH Venture Partners XIII, LLC Director · Series A Preferred Stock · 2026-06-17	Convert	5.15M	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in KARD · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.